— Know what they know.
Not Investment Advice

MCAP.ST STO

MedCap AB (publ)
1W: -3.0% 1M: -10.0% 3M: -0.7% YTD: +2.4% 1Y: -21.2% 3Y: +71.4% 5Y: +150.1%
kr 511.50 ($50.93)
-2.00 (-0.39%)
 
Weekly Expected Move ±2.5%
kr 486 kr 499 kr 512 kr 524 kr 537
STO · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 33 · kr 7.7B mcap · 12M float · 0.135% daily turnover

Cash Flow Trends

Operating Cash Flow
$343M -4.8% ▼
5Y CAGR: +24.3%
Capital Expenditures
$62M +6.0% ▲
5Y CAGR: +20.6%
Free Cash Flow
$280M -4.5% ▼
5Y CAGR: +25.2%
Dividends Paid
$0 +0.0% ▲
Buybacks
$26M +0.0% ▲
Net Change in Cash
$300K -99.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$127M$171M$172M$272M$303M
Depreciation & Amort.$76M$88M$104M$115M$153M
Stock-Based Comp.$6M$0$0$0$0
Change in Working Capital-$55M-$146M-$69M$72M$5M
Other Non-Cash Items-$31M-$27M$21M-$99M-$118M
Operating Cash Flow$116M$86M$228M$360M$343M
— Investing Activities —
Capital Expenditures-$61M-$44M-$22M-$42M-$26M
Acquisitions (Net)-$5M-$12M-$113M-$63M-$330M
Investment Purchases-$700K-$100K$0$0$0
Investment Sales$700K$100K$0$0$0
Other Investing$700K$100K-$17M-$24M-$36M
Investing Cash Flow-$65M-$56M-$152M-$129M-$391M
— Financing Activities —
Net Debt Issuance-$66M$63M-$122M-$15M$180M
Stock Repurchased$0$0$0$0-$26M
Dividends Paid$0$0$0$0$0
Other Financing$900K$100K$0-$67M-$132M
Financing Cash Flow-$64M$61M-$120M-$46M$52M
Net Change in Cash-$7M$96M-$48M$182M$300K
Cash End of Period$140M$236M$188M$370M$370M
Free Cash Flow$55M$41M$189M$294M$280M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms